ACHV
Price
$2.23
Change
-$1.28 (-36.47%)
Updated
Jun 27 closing price
Capitalization
77.37M
39 days until earnings call
AXSM
Price
$103.36
Change
+$0.79 (+0.77%)
Updated
Jun 27 closing price
Capitalization
5.09B
43 days until earnings call
Interact to see
Advertisement

ACHV vs AXSM

Header iconACHV vs AXSM Comparison
Open Charts ACHV vs AXSMBanner chart's image
Achieve Life Sciences
Price$2.23
Change-$1.28 (-36.47%)
Volume$13.06M
Capitalization77.37M
Axsome Therapeutics
Price$103.36
Change+$0.79 (+0.77%)
Volume$1.18M
Capitalization5.09B
ACHV vs AXSM Comparison Chart in %
Loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AXSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACHV vs. AXSM commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Hold and AXSM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (ACHV: $2.23 vs. AXSM: $103.36)
Brand notoriety: ACHV and AXSM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 2336% vs. AXSM: 183%
Market capitalization -- ACHV: $77.37M vs. AXSM: $5.09B
ACHV [@Biotechnology] is valued at $77.37M. AXSM’s [@Biotechnology] market capitalization is $5.09B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whileAXSM’s FA Score has 0 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • AXSM’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACHV and AXSM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 4 TA indicator(s) are bullish while AXSM’s TA Score has 1 bullish TA indicator(s).

  • ACHV’s TA Score: 4 bullish, 5 bearish.
  • AXSM’s TA Score: 1 bullish, 6 bearish.
According to our system of comparison, ACHV is a better buy in the short-term than AXSM.

Price Growth

ACHV (@Biotechnology) experienced а -33.43% price change this week, while AXSM (@Biotechnology) price change was +2.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ACHV is expected to report earnings on Aug 07, 2025.

AXSM is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXSM($5.09B) has a higher market cap than ACHV($77.4M). AXSM YTD gains are higher at: 22.160 vs. ACHV (-36.648). ACHV has higher annual earnings (EBITDA): -44.37M vs. AXSM (-262.01M). AXSM has more cash in the bank: 301M vs. ACHV (23.2M). ACHV has less debt than AXSM: ACHV (9.96M) vs AXSM (211M). AXSM has higher revenues than ACHV: AXSM (432M) vs ACHV (0).
ACHVAXSMACHV / AXSM
Capitalization77.4M5.09B2%
EBITDA-44.37M-262.01M17%
Gain YTD-36.64822.160-165%
P/E RatioN/AN/A-
Revenue0432M-
Total Cash23.2M301M8%
Total Debt9.96M211M5%
FUNDAMENTALS RATINGS
ACHV vs AXSM: Fundamental Ratings
ACHV
AXSM
OUTLOOK RATING
1..100
5284
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
10068
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
9252
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACHV's Valuation (66) in the Biotechnology industry is in the same range as AXSM (93) in the Pharmaceuticals Other industry. This means that ACHV’s stock grew similarly to AXSM’s over the last 12 months.

AXSM's Profit vs Risk Rating (68) in the Pharmaceuticals Other industry is in the same range as ACHV (100) in the Biotechnology industry. This means that AXSM’s stock grew similarly to ACHV’s over the last 12 months.

ACHV's SMR Rating (99) in the Biotechnology industry is in the same range as AXSM (100) in the Pharmaceuticals Other industry. This means that ACHV’s stock grew similarly to AXSM’s over the last 12 months.

AXSM's Price Growth Rating (52) in the Pharmaceuticals Other industry is somewhat better than the same rating for ACHV (92) in the Biotechnology industry. This means that AXSM’s stock grew somewhat faster than ACHV’s over the last 12 months.

AXSM's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as ACHV (100) in the Biotechnology industry. This means that AXSM’s stock grew similarly to ACHV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHVAXSM
RSI
ODDS (%)
Bullish Trend 3 days ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
76%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AXSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TGVRX30.280.30
+1.00%
Thornburg International Equity R3
RMVIX26.590.14
+0.53%
RBC Microcap Value I
ABECX21.940.11
+0.50%
American Beacon The London Co Inc Eq C
AMEFX26.490.04
+0.15%
American Funds Income Fund of Amer F2
GRGRX47.230.01
+0.02%
Goldman Sachs Equity Income R

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been closely correlated with HOFBF. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if ACHV jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-36.47%
HOFBF - ACHV
72%
Closely correlated
N/A
PDSB - ACHV
39%
Loosely correlated
-2.76%
IMCR - ACHV
39%
Loosely correlated
N/A
ABOS - ACHV
38%
Loosely correlated
-7.44%
GLSI - ACHV
38%
Loosely correlated
N/A
More

AXSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXSM has been loosely correlated with CRNX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if AXSM jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXSM
1D Price
Change %
AXSM100%
+0.77%
CRNX - AXSM
41%
Loosely correlated
-0.10%
ACHV - AXSM
40%
Loosely correlated
-36.47%
PLRX - AXSM
39%
Loosely correlated
-3.08%
XENE - AXSM
37%
Loosely correlated
+0.62%
IONS - AXSM
37%
Loosely correlated
N/A
More